A detailed history of Black Rock Inc. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 5,960,370 shares of SRPT stock, worth $942 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,960,370
Previous 6,211,792 4.05%
Holding current value
$942 Million
Previous $599 Million 28.82%
% of portfolio
0.02%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$93.7 - $141.53 $23.6 Million - $35.6 Million
-251,422 Reduced 4.05%
5,960,370 $772 Million
Q4 2023

Feb 13, 2024

BUY
$67.31 - $124.76 $12 Million - $22.2 Million
178,057 Added 2.95%
6,211,792 $599 Million
Q3 2023

Nov 13, 2023

BUY
$102.5 - $123.59 $54.4 Million - $65.5 Million
530,269 Added 9.64%
6,033,735 $731 Million
Q2 2023

Aug 11, 2023

BUY
$106.4 - $157.19 $23.5 Million - $34.7 Million
220,771 Added 4.18%
5,503,466 $630 Million
Q1 2023

May 12, 2023

SELL
$117.53 - $155.99 $23.4 Million - $31.1 Million
-199,471 Reduced 3.64%
5,282,695 $728 Million
Q4 2022

Feb 13, 2023

BUY
$100.86 - $132.13 $14.6 Million - $19.1 Million
144,862 Added 2.71%
5,482,166 $710 Million
Q3 2022

Nov 14, 2022

SELL
$75.71 - $119.24 $20.5 Million - $32.2 Million
-270,359 Reduced 4.82%
5,337,304 $590 Million
Q2 2022

Aug 12, 2022

BUY
$62.69 - $88.44 $3.81 Million - $5.37 Million
60,704 Added 1.09%
5,607,663 $420 Million
Q1 2022

May 12, 2022

BUY
$63.15 - $90.42 $16.5 Million - $23.7 Million
261,725 Added 4.95%
5,546,959 $433 Million
Q4 2021

Feb 10, 2022

BUY
$77.28 - $99.42 $40.6 Million - $52.2 Million
525,016 Added 11.03%
5,285,234 $476 Million
Q3 2021

Nov 09, 2021

SELL
$65.97 - $92.48 $7 Million - $9.82 Million
-106,133 Reduced 2.18%
4,760,218 $440 Million
Q2 2021

Aug 11, 2021

BUY
$69.38 - $86.75 $338 Million - $422 Million
4,866,351 New
4,866,351 $378 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $13.8B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.